Stock listing

8NE Stock Price, News, Filings & Events — Lisata Therapeutics, Inc.

Selected listing: 8NE · GETTEX · EUR · DE

The 8NE:GETTEX listing represents Lisata Therapeutics, Inc., a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. The company is actively engaged in clinical trials and research to advance its product pipeline. Recent news and filings highlight its ongoing commitment to addressing unmet medical needs in the therapeutic landscape. Investors can stay informed about upcoming events and market developments related to Lisata Therapeutics through this listing.

8NE:GETTEXEURDEUpdated July 24, 2026
Lisata Therapeutics, Inc. logo
Ticker
8NE:GETTEX
Asset type
Stock
Market cap
$15.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Lisata Therapeutics, Inc. 8NE:GETTEX stock context

The 8NE:GETTEX listing represents Lisata Therapeutics, Inc., a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. The company is actively engaged in clinical trials and research to advance its product pipeline. Recent news and filings highlight its ongoing commitment to addressing unmet medical needs in the therapeutic landscape. Investors can stay informed about upcoming events and market developments related to Lisata Therapeutics through this listing.

Research Lisata Therapeutics, Inc.

Alternate listings